Cargando…
Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudin
Autores principales: | Minhas, Abdul Mannan Khan, Assad, Salman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583620/ https://www.ncbi.nlm.nih.gov/pubmed/28900453 http://dx.doi.org/10.4103/jrms.JRMS_301_17 |
Ejemplares similares
-
No- and Low-Flow Time During Periprocedural Complication in
Transcatheter Aortic Valve Replacement and Surgical Aortic Valve
Replacement
por: Condello, Ignazio, et al.
Publicado: (2022) -
Periprocedural considerations of transcatheter aortic valve implantation for anesthesiologists
por: Afshar, Ata Hassani, et al.
Publicado: (2016) -
Commentary to the article “Transcatheter-based aortic valve replacement vs. isolated surgical aortic valve replacement in 2020”
por: Bestehorn, Kurt
Publicado: (2022) -
Redo Surgical Mitral Valve Replacement Versus Transcatheter Mitral Valve in Valve From the National Inpatient Sample
por: Zia Khan, Muhammad, et al.
Publicado: (2021) -
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial
por: Zilberszac, Robert, et al.
Publicado: (2019)